Here is an article worth reading: Link: http:
Post# of 416
Link:
http://www.nasdaqreporter.com/4-biotech-stock...asdaqexel/
4 Biotech Stocks To Watch in 2018 : Endonovo Therapeutics, Inc. (OTCQB:ENDV), Welltower Inc (NYSE:HCN), Geron Corporation (NASDAQ:GERN), and Exelixis, Inc. (NASDAQ:EXEL).
Endonovo Therapeutics, Inc. (OTCQB:ENDV)
Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals™. The Company’s current portfolio of commercial and clinical-stage wearable Electroceuticals™ addresses wound healing, pain, post-surgical edema and Central Nervous System (CNS) Disorders, including traumatic brain injury (TBI), acute concussions, post-concussion syndrome and multiple sclerosis. The Company’s current portfolio of pre-clinical stage Electroceuticals™ addresses chronic kidney disease, liver disease, cardiovascular and peripheral artery disease. The Company’s non-invasive Electroceuticals™ work by delivering electrical stimulation to tissues in order to restore key electrochemical processes that initiate anti-inflammatory and growth factor cascades necessary for healing to occur.
In a recent press release, the Company announced the first commercial sales of SofPulse™, its non-invasive, wearable Electroceutical™ device. SofPulse™ is the Company’s FDA-Cleared Electroceutical™ System for the palliative treatment of post-operative pain and edema in superficial soft tissues. Furthermore, the Company announced it is seeking distribution partners in Europe for SofPulse™, which is CE-Marked for the promotion of wound healing, reduction of pain and post-operative edema.
Full Press Release : https://www.otcmarkets.com/stock/ENDV/news/En...72&b=y
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.